BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $24.45 million. The enterprise value is $70.96 million.

Market Cap	24.45M
Enterprise Value	70.96M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

BTAI has 40.74 million shares outstanding. The number of shares has increased by 13.99% in one year.

Shares Outstanding	40.74M
Shares Change (YoY)	+13.99%
Shares Change (QoQ)	+30.40%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	14.70%
Float	29.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.83
Forward PS	3.43
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	29.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.35

Current Ratio	2.35
Quick Ratio	2.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-63.62%
Return on Capital (ROIC)	-98.33%
Revenue Per Employee	$32,473
Profits Per Employee	-$1.46M
Employee Count	74
Asset Turnover	0.02
Inventory Turnover	0.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.14% in the last 52 weeks. The beta is 0.28, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-74.14%
50-Day Moving Average	0.60
200-Day Moving Average	1.80
Relative Strength Index (RSI)	53.15
Average Volume (20 Days)	350,730

Short Selling Information

The latest short interest is 516,384, so 1.27% of the outstanding shares have been sold short.

Short Interest	516,384
Short Previous Month	697,630
Short % of Shares Out	1.27%
Short % of Float	1.74%
Short Ratio (days to cover)	0.78

Income Statement

In the last 12 months, BTAI had revenue of $2.40 million and -$107.83 million in losses. Loss per share was -$3.32.

Revenue	2.40M
Gross Profit	1.04M
Operating Income	-104.61M
Pretax Income	-107.83M
Net Income	-107.83M
EBITDA	-104.30M
EBIT	-104.61M
Loss Per Share	-$3.32

Full Income Statement

Balance Sheet

The company has $56.27 million in cash and $103.62 million in debt, giving a net cash position of -$47.35 million or -$1.16 per share.

Cash & Cash Equivalents	56.27M
Total Debt	103.62M
Net Cash	-47.35M
Net Cash Per Share	-$1.16
Equity (Book Value)	-74.30M
Book Value Per Share	-1.84
Working Capital	36.89M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-105.33M
Capital Expenditures	n/a
Free Cash Flow	-105.33M
FCF Per Share	-$2.59

Full Cash Flow Statement

Margins

Gross Margin	43.11%
Operating Margin	-4,353.35%
Pretax Margin	-4,487.39%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-4,383.15%

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.99%
Shareholder Yield	-13.99%
Earnings Yield	-456.78%
FCF Yield	-446.17%

Analyst Forecast

The average price target for BTAI is $5.00, which is 733.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	733.33%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	139.31%
EPS Growth Forecast (5Y)	-48.90%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BTAI has an Altman Z-Score of -17.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.47
Piotroski F-Score	2